211 related articles for article (PubMed ID: 27566291)
1. Ph(-) myeloproliferative neoplasm red blood cells display deregulation of IQGAP1-Rho GTPase signaling depending on CALR/JAK2 status.
Socoro-Yuste N; Dagher MC; Gonzalez De Peredo A; Mondet J; Zaccaria A; Roux Dalvai F; Plo I; Cahn JY; Mossuz P
Biochim Biophys Acta; 2016 Nov; 1863(11):2758-2765. PubMed ID: 27566291
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with
Socoro-Yuste N; Čokić VP; Mondet J; Plo I; Mossuz P
Mol Cancer Res; 2017 Jul; 15(7):852-861. PubMed ID: 28314843
[TBL] [Abstract][Full Text] [Related]
3. IQGAP1 Interaction with RHO Family Proteins Revisited: KINETIC AND EQUILIBRIUM EVIDENCE FOR MULTIPLE DISTINCT BINDING SITES.
Nouri K; Fansa EK; Amin E; Dvorsky R; Gremer L; Willbold D; Schmitt L; Timson DJ; Ahmadian MR
J Biol Chem; 2016 Dec; 291(51):26364-26376. PubMed ID: 27815503
[TBL] [Abstract][Full Text] [Related]
4. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS
Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496
[TBL] [Abstract][Full Text] [Related]
5. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Trifa AP; Bănescu C; Tevet M; Bojan A; Dima D; Urian L; Török-Vistai T; Popov VM; Zdrenghea M; Petrov L; Vasilache A; Murat M; Georgescu D; Popescu M; Pătrinoiu O; Balea M; Costache R; Coleș E; Șaguna C; Berbec N; Vlădăreanu AM; Mihăilă RG; Bumbea H; Cucuianu A; Popp RA
Br J Haematol; 2016 Jul; 174(2):218-26. PubMed ID: 27061303
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a new type of rho-GTPase regulator.
Grohmanova K; Schlaepfer D; Hess D; Gutierrez P; Beck M; Kroschewski R
J Biol Chem; 2004 Nov; 279(47):48495-504. PubMed ID: 15355962
[TBL] [Abstract][Full Text] [Related]
7. Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ; Rashid M; Ahmed N; Nadeem M; Shamsi TS
Asian Pac J Cancer Prev; 2016; 17(3):923-6. PubMed ID: 27039813
[TBL] [Abstract][Full Text] [Related]
8. The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up.
Kurtovic-Kozaric A; Islamagic E; Komic H; Bilalovic N; Eminovic I; Burekovic A; Uzunovic A; Kurtovic S
Bosn J Basic Med Sci; 2020 May; 20(2):236-247. PubMed ID: 31668145
[TBL] [Abstract][Full Text] [Related]
9. Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms.
Trung NT; Quyen DT; Hoan NX; Giang DP; Trang TTH; Velavan TP; Bang MH; Song LH
BMC Med Genet; 2019 Jun; 20(1):115. PubMed ID: 31248375
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42.
Gorisse L; Li Z; Wagner CD; Worthylake DK; Zappacosta F; Hedman AC; Annan RS; Sacks DB
J Biol Chem; 2020 Apr; 295(15):4822-4835. PubMed ID: 32094223
[TBL] [Abstract][Full Text] [Related]
11. CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
Ojeda MJ; Bragós IM; Calvo KL; Williams GM; Carbonell MM; Pratti AF
Hematology; 2018 May; 23(4):208-211. PubMed ID: 28990497
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.
Matsumoto N; Mori S; Hasegawa H; Sasaki D; Mori H; Tsuruda K; Imanishi D; Imaizumi Y; Hata T; Kaku N; Kosai K; Uno N; Miyazaki Y; Yanagihara K
Clin Chim Acta; 2016 Nov; 462():166-173. PubMed ID: 27693531
[TBL] [Abstract][Full Text] [Related]
13. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
14. The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: interfaces differ between the complexes.
Owen D; Campbell LJ; Littlefield K; Evetts KA; Li Z; Sacks DB; Lowe PN; Mott HR
J Biol Chem; 2008 Jan; 283(3):1692-1704. PubMed ID: 17984089
[TBL] [Abstract][Full Text] [Related]
15. New model for the interaction of IQGAP1 with CDC42 and RAC1.
Nouri K; Timson DJ; Ahmadian MR
Small GTPases; 2020 Jan; 11(1):16-22. PubMed ID: 28622072
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 regulates Salmonella invasion through interactions with actin, Rac1, and Cdc42.
Brown MD; Bry L; Li Z; Sacks DB
J Biol Chem; 2007 Oct; 282(41):30265-72. PubMed ID: 17693642
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Rampal R; Al-Shahrour F; Abdel-Wahab O; Patel JP; Brunel JP; Mermel CH; Bass AJ; Pretz J; Ahn J; Hricik T; Kilpivaara O; Wadleigh M; Busque L; Gilliland DG; Golub TR; Ebert BL; Levine RL
Blood; 2014 May; 123(22):e123-33. PubMed ID: 24740812
[TBL] [Abstract][Full Text] [Related]
18. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
19. IQGAP1 activates Tcf signal independent of Rac1 and Cdc42 in injury and repair of bronchial epithelial cells.
Wang Y; Wang A; Wang F; Wang M; Zhu M; Ma Y; Wu R
Exp Mol Pathol; 2008 Oct; 85(2):122-8. PubMed ID: 18625219
[TBL] [Abstract][Full Text] [Related]
20. Salmonella enterica serotype Typhimurium usurps the scaffold protein IQGAP1 to manipulate Rac1 and MAPK signalling.
Kim H; White CD; Li Z; Sacks DB
Biochem J; 2011 Dec; 440(3):309-18. PubMed ID: 21851337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
